Adagene Inc.
ADAG- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001818838
In the last 90 days, Adagene Inc. insiders filed 4 open-market purchases and 0 sales; 35 institutions reported holding it in 13F filings for Q2 2026, worth $81.0M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Adagene Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 14 | 15 | +1 |
| Shares | 7.62M | 6.07M | −1.55M (−20.3%) |
| Value | $11.6M | $11.8M | +$237.9K (+2.1%) |
New holders (3)
Institutions that held Adagene Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Kamunting Street Capital Management, L.P. | 126,032 | $245.8K | 0.20% |
| EverSource Wealth Advisors, LLC | 11,307 | $22.0K | 0.00% |
| BlackRock, Inc. | 635 | $1.24K | 0.00% |
Sold out (2)
Institutions that held Adagene Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| FIL Ltd | 749,448 | $1.15M |
| Barclays PLC | 122,516 | $186.2K |